Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What fueled the previous growth in the uterine fibroid embolization device market?
The uterine fibroid embolization devices market has seen strong growth, expected to rise from $5.62 billion in 2024 to $5.93 billion in 2025 at a CAGR of 5.6%. Growth in the historic period was driven by the increasing incidence of uterine fibroids, the shift toward non-surgical alternatives, educational initiatives, a focus on women’s health, outpatient procedure adoption, and physician training programs.
What will be the uterine fibroid embolization device market size in the future?
The uterine fibroid embolization devices market is projected to expand steadily, reaching $7.04 billion by 2029 with a CAGR of 4.4%. Growth will be driven by increasing awareness of non-invasive treatments, global healthcare expansion, female healthcare initiatives, multidisciplinary care integration, and the rise of outpatient services. Key trends include greater adoption of minimally invasive procedures, advancements in embolic agents, personalized treatment approaches, outpatient UFE procedures, integration of imaging technologies, and research into bioresorbable embolic agents.
Get your uterine fibroid embolization device market report here!
What main drivers are fueling expansion in the uterine fibroid embolization device market?
The burgeoning need for less invasive medical procedures is set to accelerate the growth of the uterine fibroid embolization device market. These less invasive surgical methods use tiny incisions or body openings to reach and treat internal organs, structures, or tissues, causing less damage to the patient’s body. Uterine fibroid embolization devices have a crucial role in facilitating these less invasive surgeries, treating uterine fibroids efficiently. These uniquely designed devices aim to lessen invasiveness through tiny incisions, thereby reducing the effects on nearby tissues. They are designed to meet the rising demand for surgical procedures that are less invasive, consequently enhancing patient outcomes. For example, The Aesthetic Society, an American organization of plastic surgery and cosmetic medicine, declared in August 2023 that expenditure on aesthetic procedures in the US was more than $11.8 billion, experiencing an increase of 2% compared to the previous year. Hence, the surging demand for less invasive surgeries stimulates the uterine fibroid embolization device market’s growth.
Uterine Fibroid Embolization Device Market Driver: Increase in Aged Population Boosts Growth in Uterine Fibroid Embolization Devices Market
What key areas define the segmentation of the global uterine fibroid embolization device market?
The uterine fibroid embolization device market covered in this report is segmented –
1) By Technology: Surgical Techniques, Laparoscopic Techniques, Ablation Techniques, Embolization Techniques
2) By Mode Of Treatment: Invasive Treatment, Minimally Invasive Treatment, Non-Invasive Treatment
3) By End User: Hospitals, Clinics, Ambulatory Surgical Center
Subsegments:
1) By Surgical Techniques: Open Surgery, Myomectomy
2) By Laparoscopic Techniques: Laparoscopic Myomectomy, Laparoscopic Hysterectomy
3) By Ablation Techniques: Radiofrequency Ablation, Microwave Ablation, Cryoablation
4) By Embolization Techniques: Transcatheter Arterial Embolization (TAE), Uterine Artery Embolization (UAE)
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13551&type=smp
Who are the dominant players expanding their reach in the uterine fibroid embolization device market?
Major companies operating in the uterine fibroid embolization device market report are Johnson and Johnson Pvt Ltd., Abbott Laboratories, Medtronic plc., Siemens Healthineers Ltd., Koninklijke Philips N.V., Stryker Corporation, Boston Scientific Corporation, GE HealthCare Technologies Inc., Olympus Corporation, Terumo Corporation, Smith and Nephew plc., Ethicon Inc., Hologic Inc., CooperSurgical Inc., Ferring B.V., Cook Medical Inc., Karl Storz GmbH, Merit Medical Systems, CONMED Corporation, Amsino International Inc., Lumenis Ltd., Richard Wolf GmbH, BTG International Ltd., Healthium MedTech Pvt. Ltd., INSIGHTEC Ltd., Hironic Co.Ltd., Minerva Surgical Inc., Gynesonics Inc., Advanced Surgical Concepts PLLC, Hitachi Medical Corporation
How are evolving market trends shaping uterine fibroid embolization device Strategies?
A leading player in the uterine fibroid embolization device market, Medtronic Private Limited, an India-based healthcare technology company, launched an innovative product called the TruClear system in November 2022. This new invention was designed to meet the escalating demand for less invasive procedures in the treatment of uterine fibroids, enhancing both the safety and effectiveness of these treatments. The TruClear system works as a mechanical hysteroscopic tissue removal device, aiming to treat intrauterine abnormalities (IUA). This tool is introduced into the uterus via the cervix and is distinguished by its compact nature and flexibility. The inclusion of a rotating nitinol wire loop, consistent inflow and outflow, inbuilt suction, and high-resolution imaging further enhances the precision and safety of the treatment methods for uterine fibroids.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13551
Which regions are emerging as leaders in the uterine fibroid embolization device market?
North America was the largest region in the uterine fibroid embolization device market in 2024. The regions covered in the uterine fibroid embolization device market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Magnetic Resonance Imaging Systems Devices And Equipment Global Market Report 2024
Immunochemistry Diagnostic Devices And Equipment Global Market Report 2024
Lancing Devices And Equipment Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/lancing-devices-and-equipment-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
